Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
PRAME inhibitor
DRUG CLASS:
PRAME inhibitor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
IMC-F106C (2)
BPX-701 (0)
CVT-DC-01 (0)
IMA203 (0)
IMA203CD8 (0)
IMA402 (0)
MANA-312 (0)
MDG1011 (0)
MultiTAA T cell therapy (0)
NEXI-001 (0)
multiplexed MAGEA1/PRAME TCR-T cell therapy (0)
IMC-F106C (2)
BPX-701 (0)
CVT-DC-01 (0)
IMA203 (0)
IMA203CD8 (0)
IMA402 (0)
MANA-312 (0)
MDG1011 (0)
MultiTAA T cell therapy (0)
NEXI-001 (0)
multiplexed MAGEA1/PRAME TCR-T cell therapy (0)
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
PRAME expression
Ovarian Cancer
PRAME expression
Ovarian Cancer
IMC-F106C
Sensitive: C3 – Early Trials
IMC-F106C
Sensitive
:
C3
IMC-F106C
Sensitive: C3 – Early Trials
IMC-F106C
Sensitive
:
C3
PRAME expression
Non Small Cell Lung Cancer
PRAME expression
Non Small Cell Lung Cancer
IMC-F106C
Sensitive: C3 – Early Trials
IMC-F106C
Sensitive
:
C3
IMC-F106C
Sensitive: C3 – Early Trials
IMC-F106C
Sensitive
:
C3
PRAME expression
Solid Tumor
PRAME expression
Solid Tumor
PRAME inhibitor
Sensitive: D – Preclinical
PRAME inhibitor
Sensitive
:
D
PRAME inhibitor
Sensitive: D – Preclinical
PRAME inhibitor
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login